GLAUCOMA 1, OPEN ANGLE, D (Disorder)
6
2
2
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 6 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (6)
Comparing XEN®-63 Gel Stent and PRESERFLO® MicroShunt
24-hour Wear Performance and Safety Study of Smartlens miLens Contact Lens for IOP Monitoring
Preserflo MicroShunt Versus Trabeculectomy
Comparison of Visual Outcomes and Patient Satisfaction in Mild to Moderate Glaucoma Patients Undergoing Cataract Surgery With EDOF Versus Monofocal IOLs
Direct vs. Conventional SLT in Open-Angle Glaucoma: A RCT
Spectral Domain Optical Coherence Tomography Analysis for Glaucoma